How much does Azelastine Hydrochloride Ophthalmic Solution 0.05% cost?

Pricing for Azelastine Hydrochloride Ophthalmic Solution 0.05% varies by insurance plan, dose, and pharmacy. Our database does not show a fixed cost because prices change faster than we can verify. For current pharmacy prices, check your insurance's formulary tier (in the prior-authorization section), use the GoodRx or Cost Plus Drugs deep links on this page, or ask your pharmacist to run a test claim. If a copay card is listed, it usually drops the out-of-pocket significantly for commercial insurance.

Does Azelastine Hydrochloride Ophthalmic Solution 0.05% need prior authorization?

Azelastine Hydrochloride Ophthalmic Solution 0.05% appears on 1 payer formulary in our database. PA requirements vary by payer — see the prior-authorization table on this page for specifics. In general, specialty and brand-name drugs are more likely to require PA than generic equivalents.

Is there a copay card or patient assistance program for Azelastine Hydrochloride Ophthalmic Solution 0.05%?

We haven't verified an active copay card or PAP for Azelastine Hydrochloride Ophthalmic Solution 0.05% in our current data. Check NeedyMeds or RxAssist for independent directories, or submit what you find via our "Report a broken link" form.

Azelastine Hydrochloride Ophthalmic Solution 0.05% — copay help & patient assistance

Q: What is Azelastine Hydrochloride Ophthalmic Solution 0.05% used to treat?

Azelastine Hydrochloride Ophthalmic Solution 0.05% is indicated for Allergic Conjunctivitis, Conjunctivitis, Itching and 1 other condition. Click any condition name on this page for more detail.

Affordability Check

How much will you actually pay for Azelastine Hydrochloride Ophthalmic Solution 0.05%?

In 30 seconds, see every legitimate way to afford Azelastine Hydrochloride Ophthalmic Solution 0.05% — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Azelastine Hydrochloride Ophthalmic Solution 0.05%

What is this medication? Azelastine hydrochloride ophthalmic solution 0.05 percent is an antihistamine medication designed to relieve the symptoms of allergic conjunctivitis. It is specifically used to treat itchy eyes caused by seasonal allergens such as pollen and grass, as well as year-round triggers like pet dander and dust mites. The solution works by blocking histamine receptors in the eye, which prevents the inflammatory response that leads to itching and discomfort.

The medication is typically administered as a single drop into each affected eye twice daily. It provides relatively fast relief and helps manage the eye irritation associated with environmental allergies. Patients who wear contact lenses should remove them before applying the medication and wait at least ten minutes before reinserting them to ensure the drops are fully absorbed and do not interfere with the lenses.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Azelastine Hydrochloride Ophthalmic Solution 0.05%.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup Azelastine Hydrochloride Ophthalmic Solution 0.05% →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for Azelastine Hydrochloride Ophthalmic Solution 0.05% →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Azelastine Hydrochloride Ophthalmic Solution 0.05%. Official source: DailyMed (NLM) · Label effective Jan 2, 2025

Indications and usage

INDICATIONS & USAGE Azelastine hydrochloride ophthalmic solution 0.05% is indicated for the treatment of itching of the eye associated with allergic conjunctivitis.

Dosage and administration

DOSAGE & ADMINISTRATION The recommended dose is one drop instilled into each affected eye twice a day.

Contraindications

CONTRAINDICATIONS Azelastine hydrochloride ophthalmic solution 0.05% is contraindicated in persons with known or suspected hypersensitivity to any of its components.

Warnings

WARNINGS Azelastine hydrochloride ophthalmic solution 0.05% is for ocular use only and not for injection or oral use.

Adverse reactions

ADVERSE REACTIONS In controlled multiple-dose studies where patients were treated for up to 56 days, the most frequently reported adverse reactions were transient eye burning/stinging (approximately 30%), headaches (approximately 15%) and bitter taste (approximately 10%). The occurrence of these events was generally mild. The following events were reported in 1–10% of patients: asthma, conjunctivitis, dyspnea, eye pain, fatigue, influenza-like symptoms, pharyngitis, pruritus, rhinitis and temporary blurring. Some of these events were similar to the underlying disease being studied.

Use in pregnancy

PREGNANCY Teratogenic Effects: Pregnancy Category C. Azelastine hydrochloride has been shown to be embryotoxic, fetotoxic, and teratogenic (external and skeletal abnormalities) in mice at an oral dose of 68.6 mg/kg/day (57,000 times the recommended ocular human use level). At an oral dose of 30 mg/kg/day (25,000 times the recommended ocular human use level), delayed ossification (undeveloped metacarpus) and the incidence of 14th rib were increased in rats. At 68.6 mg/kg/day (57,000 times the maximum recommended ocular human use level) azelastine hydrochloride caused resorption and fetotoxic effects in rats. The relevance to humans of these skeletal findings noted at only high drug exposure levels is unknown. There are no adequate and well-controlled studies in pregnant women. Azelastine hydrochloride ophthalmic solution 0.05% should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

Payer	PA	Step therapy	Copay tier
— Medicare Part D	—	—	—

Payer

PA

Step therapy

Copay tier

—

Medicare Part D

—